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Abstract
Objective. To determine population-based estimates for the prevalence of the person with OA, predicted
to be the single greatest cause of disability in the general population by 2030, in order to inform the
planning and commissioning of health, social care and prevention services.
Methods. A postal survey to all adults 550 years of age registered with eight general practices in the UK.
Self-reported data on chronic joint pain in four body regions (hand, hip, knee, foot) and the disabling
nature of the pain was collected to determine gender and age-group specific prevalence estimates of
clinical OA in the joint region and in the person. Multiple imputation and weighted logistic regression was
used to allow for missing data.
Results. A total of 26 705 mailed surveys resulted in 18 474 responses (adjusted response = 71.8%).
Approximately half of the mailed population had OA in at least one of the four regions (53.23%, 95%
CI 52.3, 54.1) and less than half of these had disabling OA (21.87%, 95% CI 21.2, 22.5). The more joint
regions involved, the more likely that the OA was disabling. OA prevalence was higher in females and
increased with age. Applied to the population of England, this yielded an estimated 3.5 million persons
with disabling OA, including 1.45 million people between 50 and 65 years of age and 370 000 585 years
of age.
Conclusions. A simple approach to defining the person with OA can contribute to population compari-
sons, public health projections and health care needs assessments.
Key words: osteoarthritis, epidemiology, prevalence, service planning.
Introduction
OA is a major cause of disability around the world [1]. In
the UK it is the most common chronic condition seen in
primary care [2], and it is predicted to be the single
greatest cause of disability in the general population by
2030 [3]. The potential to prevent, control and treat OA
underlines its public health importance [4].
Although OA is understood as a structural joint disease,
typified radiographically by cartilage loss and bone
changes, it is also a clinical syndrome of pain, stiffness
and restricted mobility, and people with similar X-ray
appearances can have different symptoms and degrees
of disability in their daily lives. Influences on structural OA
include systemic joint disease and damage (genetic,
metabolic, inflammatory), local risks (undue mechanical
stress, injury, childhood structural anomalies, repetitive
use), age-related tissue changes (cell senescence,
increased bone turnover) and function (sarcopenia,
reduced proprioception) [5]. Other structural changes,
such as synovitis [6], may contribute to OA pain.
However, the clinical syndrome of OA is often influenced
by a broader set of factors than radiographically defined
OA alone. Factors such as muscle strength, mood, cog-
nition and co-morbid illness affect joint pain and disability
[7]. The burden of OA also depends on the individual con-
text—e.g. occupation and the availability of social support
or public transport [8]. This complex mixture of ageing,
disease, symptoms, mobility restriction and the psycho-
social environment constitutes the phenomenon of OA in
populations [9, 10].
However, information about the occurrence and burden
of symptomatic and disabling OA in populations is
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currently based on studies of disease in individual joints or
of recalled diagnosis of arthritis from a health professional
[9]. There is a strong case that the planning and commis-
sioning of health, social care and prevention services for
OA needs to focus on people with OA rather than on
individual joint diseases [11, 12]. This article uses self-
reported data from a large population-based cohort of
older adults to determine population estimates of the
prevalence of the person with OA in order to address
this gap.
Methods
The design was a two-stage cross-sectional postal survey
of an older adult population using questionnaires [the
baseline phase of the North Staffordshire Osteoarthritis
Project (NorStOP)]. The two stages involved an initial
Health Survey (HS) and a subsequent Regional Pains
Survey (RPS). Ethical approval was from the North
Staffordshire Research Ethics Committee (references
1351 and 1430). A completed returned questionnaire
provided consent for inclusion.
Study population
Full details of the study design, methods and re-
sponse have been presented elsewhere [13, 14]. The sam-
pling frame was all adults 550 years of age registered
with eight primary care general practices in North
Staffordshire, UK. The general practitioners screened
out people with severe psychiatric or terminal illness
from the mailing. In the UK 98% of the population are
registered with a GP and practice registers provide a con-
venient frame for sampling a local population, regardless
of the extent or nature of any contacts with the practice.
Baseline questionnaires were mailed, and reminders were
sent to non-responders after 2 and 4 weeks.
Questionnaires
Stage 1—the HS questionnaire
This included information on socio-demographics [15, 16],
general and mental health [17, 18], the presence of joint
pain and interference of pain [17].
For each of the four joint regions (hand, hip, knee and
foot) participants were asked, ‘Have you had any pain
in your (joint region) over the last year?’ Those responding
positively to any of these four questions and giving per-
mission for further contact were mailed the RPS
questionnaire.
The impact of pain was measured using a single item
from the Medical Outcomes Study Short Form 12 (MOS
SF-12) [‘During the past 4 weeks, how much did pain
interfere with your normal work (including both work out-
side the home and housework?)’] [17], which has five
response options, dichotomized for this analysis: (i) Pain
interference—Moderately, Quite a bit or Extremely and
(ii) No pain interference—Not at all or A little bit. This
approach has been used in previous population-based
surveys of pain [14, 1923].
Stage 2—the RPS questionnaire
For each joint region, data were gathered on the duration
of pain in the last 12 months (<7 days, 14 weeks, more
than 1 month but <3 months, 3 months or more) and a
joint-specific measure of pain and function [Australian/
Canadian (AUSCAN) OA Hand Index for hands [24],
WOMAC for hips and knees [25] and Manchester Foot
Pain and Disability Index (FPDI) for feet] [26].
Definition of OA
Three questionnaire components were used to define and
characterize OA at the joint region level and the person
level, i.e. presence and duration of pain in the four joint
regions and pain interference using the single SF-12
item [17].
For each joint region (hand, hip, knee, foot), two region-
level definitions were applied: (i) OA—presence of pain
lasting >3 months in the last 12 months, and (ii) disabling
OA—OA plus the presence of pain interference.
The definition of OA in the person drew on these two
region-level definitions as follows: (i) OA in the per-
son—presence of OA in one or more of the four joint
regions and (ii) disabling OA in the person—OA in the
person plus the presence of pain interference.
At the person level, the sum of the number of painful
joint regions with OA or disabling OA (from zero to four)
provided a grading of the extent of OA or disabling OA in
the person. We classified and estimated the extent of OA
and disabling OA as (i) one or more joint regions, (ii) two or
more regions, (iii) three or more regions and (iv) all four
regions.
Statistical analysis
The sample eligible for the prevalence analysis were all
those not excluded at any stage of the study from either
the GP screen or during the mailing. The definitions above
were applied to calculate prevalence estimates of OA and
disabling OA for each joint region and for the whole
person, overall, by gender, by age group (5054, 5559,
6064, 6569, 7074, 7579, 8084, 585 years) and by
age group within gender.
Missing data were defined on two levels: (i) item
level—questionnaire(s) had been completed but single
items were missing and (ii) study level—no questionnaires
were completed by the individual.
Multiple imputation using chain equations [27] was used
to impute missing data at the item level using the ICE
command in Stata 11 (StataCorp, College Station, TX,
USA). Putative auxiliary variables for inclusion in the im-
putation included all the socio-demographic and general
health data, and the joint region-specific measures of pain
and function. A single imputation process was applied to
all baseline responders to impute all baseline variables of
interest using appropriate distributions (linear, logistic, or-
dinal and multinomial logistic regression for numerical,
binary, ordinal categorical and nominal categorical vari-
ables, respectively). The number of imputations was set
at 20 and imputed data sets were combined using Rubin’s
combination rules [28]. The logit command was used to
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determine the coefficients (b) (and 95% CIs) from a logistic
model from which the prevalence estimates (and 95% CIs)
were calculated [prevalence = eb/(1 + eb)] for the total
baseline responder population.
Weighted estimates were used to adjust for missing
data at the study level, to account for any initial selective
non-response. Information on age, gender and general
practice location was available for all individuals. This
information was used to determine a weight to reflect
the likelihood that a person with a particular combination
of age, gender and practice location would return the
baseline HS questionnaire. Weighted logistic regression
within the imputed data sets was performed to determine
prevalence estimates (and 95% CIs) in the total baseline
eligible mailed population.
Application of prevalence estimates to
standard populations
The derived prevalence estimates of the person with dis-
abling OA were applied to the age- and gender-stratified
population distribution for England, taken from the 2001
census [29], to determine the number of people >50 years
of age with disabling OA in England and the number of
people >50 years of age with disabling OA in an average
population of 100 000 served by a general practice health
care commissioning group.
Results
After 605 exclusions before mailing, there were 26 100
adults 550 years of age in the eligible mailed population
[54.3% female; mean age 66.0 (S.D. 10.7) years]. A total of
18 474 individuals returned their HS questionnaire. The
imputation process was performed on missing items of
data in these 18 474 individuals [55.8% female; mean
age 66.2 (S.D. 10.2) years]. The weighted logistic regres-
sion analysis then extrapolated the results of the imputed
analysis of the 18 474 HS questionnaire responders to the
full initial eligible target population of 26 100 persons.
Using these combined techniques, prevalence estimates
were almost identical in the baseline responder population
and the total baseline eligible mailed population, hence
the latter data are presented.
Prevalence estimates
Prevalence estimates at the level of the joint region in the
total baseline eligible mailed population, overall and by
age group, are presented in Table 1. Prevalence estimates
were highest for knees and hands, twice as high for each
chronic joint pain as for chronic interfering pain and higher
in females than males for all four joint regions. Estimates
generally increased with age, particularly for chronic,
interfering pain.
Prevalence estimates for OA in the person are shown in
Table 2. Approximately half of this population had OA in at
least one of the four joint regions [prevalence 53.23%
(95% CI 52.3, 54.1)], which was more than twice the
prevalence of disabling OA in the person [21.87% (21.2,
22.5)]. The proportional difference between OA and dis-
abling OA estimates decreased as the extent of OA
increased, indicating that the more joint regions that
were involved, the more likely that person reported pain
interference. Estimates of OA and disabling OA for per-
sons reporting pain in all four joint regions were therefore
quite close [OA: 4.15% (3.8, 4.5) and disabling OA: 3.27%
(3.0, 3.6)].
The prevalence of OA in the person was higher in
females than males and generally increased with age
(Tables 2 and 3, Fig. 1A and B). Almost 25% of females
>50 years of age have disabling OA, increasing to 39% in
females >85 years of age. The proportion of persons with
OA increases with age regardless of the presence of dis-
ability or the number of sites affected. At any age
>50 years, the prevalence of OA is greater for persons
reporting multiple region involvement than for those with
single-region pain only.
Estimated numbers, using the English population
and commissioning groups as an example
Applying the prevalence estimates to population data
suggests 3 510 378 persons 550 years of age have dis-
abling OA in England. In a typical unit of population of
TABLE 1 Prevalence estimates for OA in the joint region: overall and by gender
Joint region
Hand Hip Knee Foot
OA Disabling OA OA Disabling OA OA Disabling OA OA Disabling OA
Overall 26.54 12.56 19.16 10.77 30.65 14.91 23.15 11.65
(25.8, 27.3) (12.0, 13.1) (18.5,19.8) (10.3, 11.3) (29.9, 31.4) (14.3, 15.5) (22.4, 23.9) (11.1, 12.2)
Gender
Female 30.53 14.66 21.84 12.49 33.06 16.47 26.67 13.52
(29.5, 31.5) (13.9, 15.4) (21.0, 22.7) (11.8, 13.2) (32.0, 34.1) (15.7, 17.3) (25.7, 27.7) (12.8, 14.3)
Male 21.79 10.06 15.96 8.72 27.77 13.03 18.96 9.42
(20.8, 22.8) (9.4, 10.8) (15.0, 17.0) (8.1, 9.4) (26.7, 28.9) (12.3, 13.9) (18.0, 20.0) (8.7, 10.2)
Values within brackets are 95% confidence intervals.
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100 000 people for health services commissioning in
England, slightly more than 7000 persons 550 years of
age are estimated to have disabling OA (Table 3).
Discussion
This article concerns the clinical syndrome of OA and pre-
sents a practical approach to defining the person with OA
and the person with disabling OA for population needs
assessment. These definitions are not intended to replace
clinical diagnosis of individual patients in everyday prac-
tice, but we argue that they do provide a useful approach
to classifying persons for epidemiological and planning
purposes. Their application in a self-administered popula-
tion survey shows that most people with OA have pain in
more than one joint region and proportionately more
women than men have OA. Although joint pain generally
increases with age, the sharpest increase occurs among
people who have pain that interferes—39% of persons
585 years of age compared with 15% of persons age
5054 years. However, these figures also mean that OA
is not an inevitable consequence of ageing and prevention
is a plausible target for health care.
We explored the validity of our survey estimates. There
were missing data in the returned questionnaires. We
investigated this by using imputation based on a range
TABLE 2 Prevalence estimates for OA in the person: overall and by gender and age group
Definition of OA
14 regions 24 regions 34 regions All 4 regions
OA Disabling OA OA Disabling OA OA Disabling OA OA Disabling OA
Overall 53.23 21.87 28.75 15.73 13.37 9.02 4.15 3.27
(52.3, 54.1) (21.2, 22.5) (28.0, 29.5) (15.2, 16.3) (12.8, 14.0) (8.6, 9.5) (3.8, 4.5) (3.0, 3.6)
Female 57.39 23.85 32.95 18.07 16.35 10.99 5.41 4.23
(56.3, 58.5) (23.0, 24.7) (31.9, 34.0) (17.3, 18.9) (15.5, 17.3) (10.3, 11.7) (4.9, 5.9) (3.8, 4.7)
Male 48.28 19.51 23.74 12.98 9.82 6.67 2.65 2.13
(47.0, 49.6) (18.6, 20.4) (22.7, 24.8) (12.2, 13.7) (9.1, 10.6) (6.1, 7.3) (2.3, 3.1) (1.8, 2.5)
Age group, years
5054 46.03 15.26 21.21 10.23 9.04 5.76 2.94 2.31
(43.9, 48.2) (13.9, 16.8) (19.5, 23.0) (9.0, 11.6) (7.8, 10.4) (4.9, 6.8) (2.3,3.8) (1.7, 3.0)
5559 42.35 16.76 25.53 12.29 12.27 7.93 4.01 3.31
(47.2, 51.3) (15.3, 18.3) (23.8, 27.4) (11.0, 13.7) (10.9, 13.7) (6.9, 9.1) (3.3, 4.9) (2.7, 4.1)
6064 52.50 19.95 28.74 14.88 12.97 8.27 4.17 3.07
(50.6, 54.3) (18.6, 21.4) (27.2, 30.4) (13.7, 16.2) (11.8, 14.2) (7.4, 9.3) (3.5, 5.0) (2.5, 3.8)
6569 54.77 20.77 30.82 15.23 14.16 8.98 4.26 3.27
(52.6, 56.9) (19.1, 22.5) (28.8, 32.9) (13.8, 16.8) (12.7, 15.8) (7.7, 10.4) (3.4, 5.3) (2.5, 4.2)
7074 55.42 23.01 30.17 16.54 14.67 9.77 4.26 3.13
(53.4, 57.5) (21.5, 24.6) (28.4, 31.1) (15.2, 18.0) (13.3, 16.2) (8.6, 11.0) (3.5, 5.1) (2.5, 3.9)
7579 56.60 26.04 31.81 19.21 15.05 11.01 4.70 3.93
(53.8, 59.4) (23.9, 28.2) (29.3, 34.4) (17.3, 21.3) (13.2, 17.1) (9.4, 12.8) (3.7, 6.0) (3.0, 5.1)
8084 58.93 31.79 34.11 22.28 16.09 11.98 4.74 4.06
(56.2, 61.7) (29.5, 34.2) (31.5, 36.8) (20.2, 24.5) (14.0, 18.4) (10.3, 13.9) (3.7, 6.1) (3.1, 5.3)
585 62.29 38.83 35.56 26.59 16.76 13.61 4.74 4.53
(58.0, 66.4) (35.2, 42.5) (31.8, 39.5) (23.3, 30.2) (14.0, 20.0) (11.2, 16.5) (3.7, 6.1) (3.2, 6.4)
Values within brackets are 95% confidence intervals.
TABLE 3 Population estimates for disabling OA in the
person: England and an average-sized commissioning
group
Population data for prevalence
of disabling OA
England
(n=49138 831)
Average-sized
commissioning
group
(n=100000)
Overall 3 510 378 7144
Gender
Female 2 096 555 4267
Male 1 413 823 2877
Age group, years
5054 514 610 1047
5559 465 233 946
6064 477 204 971
6569 447 165 910
7074 448 241 912
7579 431 142 877
8084 353 914 720
585 372 869 759
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of survey information. There was also a 29% non-
response to the survey. We adjusted for this by applying
weighted estimates from the responder population to the
age, gender and GP practice structure of the target sur-
veyed population. Changes in estimates following these
combined approaches were minimal.
The definition of clinical OA in populations
An important concern to address is our use of self-
reported joint pain and interference with daily life in an
older population as the basis for defining OA.
Estimates of the global burden of disease and local
population-based health care needs assessments related
to OA have traditionally focused on radiographic defin-
itions of OA at specific joint sites [30, 31]. Although this
is reasonable for aetiological studies (e.g. what causes
structural OA in the hip and how might it be prevented)
and in helping treatment decisions in some individual pa-
tients (e.g. the need for an X-ray prior to knee replacement
surgery), this is insufficient for even targeted assessments
of health care needs at a population level (e.g. how many
people have hip OA sufficiently severe for joint replace-
ment), since decisions related to a structurally focused
FIG. 1 Prevalence estimates for definitions of disabling clinical OA in the person.
(A) Females by age group. (B) Males by age group.
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treatment such as joint replacement are informed by the
degree of interference with daily life as well as by the
severity of radiographic change [10]. Hence the focus in
recent studies has shifted towards pain and disability at
specific joint sites, with or without radiographic measures,
i.e. towards clinical OA as the condition of interest [9, 10].
Further justification for using a symptom definition for
population purposes is provided by recent work [32]
which, by carefully adjusting for confounding, has identi-
fied a much closer association between the severity of
radiographic features of OA at the knee and pain in that
joint compared with previous reports.
This then leaves the final argument for the choice of
joint pain to represent clinical OA in population studies
resting on the assumption that OA is the most common
cause of pain in this age group. There is evidence to sup-
port this assumption. In a clinical assessment substudy of
NorStOP (including X-rays), the proportion of persons with
chronic hand pain and pain interference who had definite
radiographic hand OA was 81%, and the equivalent figure
for the knee was 78%, whereas the number of people with
a joint disease other than OA in their medical record was
16 out of >800 persons with knee pain [33] and 28 out of
>600 persons with hand pain [34].
Our conclusion is that evidence from a range of sources
suggests that the phenotype of self-reported joint pain
and pain that interferes in persons 550 years of age suf-
ficiently reflects other recognized OA phenotypes (radio-
graphic change, use of the label of OA in primary care) to
be acceptable as the basis for population measures of the
person with OA. As with many public health measures,
this definition is crude, and a degree of misclassification
has to be accepted, but it fits a particular purpose of
estimating population burden. It may be less appropriate
for assessing or evaluating the individual patient.
The definition of OA in the whole person
Regardless of how OA itself is defined, prevalence esti-
mates of OA in specific joints do not provide a clear basis
for informing health and social care needs and preventive
services for all persons with OA since, as confirmed here,
most people with OA have problems at more than one
joint site and core treatment for OA (pain relief, exercise,
weight reduction, self-management) is similar regardless
of the joint location [4]. A recent systematic review high-
lighted that measuring OA in the population has largely
relied on a recalled diagnosis of arthritis or OA from a
health professional [9]. It found variability of prevalence
estimates arose from different measures of the problem
(recalled diagnosis, radiographic, symptom-based), and
the accompanying editorial [7] called for more attention
on the person with OA. However, for specific questions
about health care needs, different definitions and analyses
may be needed [31]. A specific example would be the
estimation of the number of persons requiring a joint
replacement or the potential costs of joint replacement
surgery, where the approach proposed here would
not be appropriate on its own and would need
supplementation to provide estimates at a joint-specific
level and include information on radiographic severity.
One potential concern is that our definition of the
person with OA includes the foot. Textbook definitions
focus on the hand, knee and hips as major OA sites, but
accept that any synovial joint may be affected by radio-
graphic and clinical syndromes. The frequency of OA in
joints other than the foot, however, is low compared with
the hand, knee and hip, whereas the proportion of foot
pain in older people that could be OA is unclear. To inves-
tigate this we recalculated disabling OA prevalence in the
person excluding the foot. This figure was 20.78% (95%
CI 20.2, 21.4), very similar to the prevalence including the
foot (21.87%; Table 2). This means the foot does not add
to the definition of disabling OA in the person. However,
inclusion of the foot does contribute to grading of the
number of joint regions involved and we retained it in
the definition of the person with OA.
Our figures for disabling OA in the person are a little
lower than estimates based on the ACR criteria using
combined self-report, radiographic and clinical assess-
ment data [35, 36]. These studies either did not estimate
prevalence in the person or did so by adding up preva-
lence figures for individual joints, which inevitably results
in overestimates.
Primary care data sets with clinician diagnostic labels
provide an alternative resource for estimating population
prevalence of the person with OA. Our estimates for dis-
abling OA are rather lower than the 10-year period preva-
lence of diagnosed OA reported from an analysis of
persons with OA in a primary care clinical database [37],
which may reflect the contrast between currently trouble-
some OA and OA intermittently troublesome over a
period. However, these contrasting approaches to deter-
mining the population prevalence of disabling OA—self-
report vs clinical consultation history—do seem to provide
compatible and comparable estimates of OA in the
person.
Conclusion
In summary, we propose that the definition and approach
developed here provides an appropriate basis for estimat-
ing the number and distribution of persons with OA in
local, regional and national populations, and for compari-
son between such populations. Three dimensions, easily
captured by self-complete questions, identify subgroups
of increasing severity—chronicity and pain interference
provide the core definitions of disabling OA, and the
number of joint regions is a simple measure of ‘how
much OA have you got?’, which has associations with
other measures of societal and personal impacts of
OA [38].
Research on interventions for persons with co-morbid
chronic diseases has highlighted the need to balance
condition-specific management (e.g. diabetic control,
joint replacements, heart failure therapy) with interven-
tions common to many different chronic conditions
(e.g. weight reduction, physical activity, positive cogni-
tions, anti-depression therapies) [39, 40]. A focus on the
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person with OA will help to integrate these two
approaches.
Rheumatology key messages
. There is a need for more attention on people with
OA.
. Twenty per cent of people reported disabling OA,
which was higher in females and those of older age.
. An estimated 3.5 million persons have disabling OA
in the UK.
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